Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 94(10): 5119-24, 1997 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-9144200

RESUMEN

When T cells become infected by the parasite Theileria parva, they acquire a transformed phenotype and no longer require antigen-specific stimulation or exogenous growth factors. This is accompanied by constitutive interleukin 2 (IL-2) and IL-2 receptor expression. Transformation can be reversed entirely by elimination of the parasites using the specific drug BW720c. Extracellular signal-regulated kinase and jun NH2-terminal kinase (JNK) are members of the mitogen-activated protein kinase family, which play a central role in the regulation of cellular differentiation and proliferation and also participate in the regulation of IL-2 and IL-2 receptor gene expression. T. parva was found to induce an unorthodox pattern of mitogen-activated protein kinase expression in infected T cells. JNK-1 and JNK-2 are constitutively active in a parasite-dependent manner, but have altered properties. In contrast, extracellular signal-regulated kinase-2 is not activated even though its activation pathway is functionally intact. Different components of the T cell receptor (TCR)-dependent signal transduction pathways also were examined. The TCRzeta or CD3epsilon chains were found not to be phosphorylated and T. parva-transformed T cells were resistant to inhibitors that block the early steps of T cell activation. Compounds that inhibit the progression of T cells to proliferation, however, were inhibitory. Our data provide the first example, to our knowledge, for parasite-mediated JNK activation, and our findings strongly suggest that T. parva not only lifts the requirement for antigenic stimulation but also entirely bypasses early TCR-dependent signal transduction pathways to induce continuous proliferation.


Asunto(s)
Antiprotozoarios/farmacología , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Activación de Linfocitos , Proteínas Quinasas Activadas por Mitógenos , Naftoquinonas/farmacología , Proteínas Quinasas/metabolismo , Linfocitos T/fisiología , Linfocitos T/parasitología , Tacrolimus/análogos & derivados , Theileria parva/fisiología , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Animales , Línea Celular , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Inmunosupresores/farmacología , Indoles/farmacología , Proteínas Quinasas JNK Activadas por Mitógenos , Cinética , Ganglios Linfáticos/inmunología , Maleimidas/farmacología , Proteína Quinasa 9 Activada por Mitógenos , Polienos/farmacología , Proteína Quinasa C/antagonistas & inhibidores , Complejo Receptor-CD3 del Antígeno de Linfocito T/aislamiento & purificación , Complejo Receptor-CD3 del Antígeno de Linfocito T/fisiología , Sirolimus , Linfocitos T/inmunología , Tacrolimus/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA